From the Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden (Bro); Department of Clinical Science/Ophthalmology, Umeå University, Umeå, Sweden (Behndig, Viberg, Thorburn); Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden (Zetterberg, Stenevi); Division of Ophthalmology and Vision, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden (Kugelberg); Capio Medocular AB, Malmö, Sweden (Nilsson); Department of Clinical Sciences/Ophthalmology, Faculty of Medicine, Lund University, Lund, Sweden (Lundström).
J Cataract Refract Surg. 2023 Aug 1;49(8):879-884. doi: 10.1097/j.jcrs.0000000000001209.
The present review summarizes data collected by the Swedish National Cataract Register (NCR), which by the end of 2021 contained data for more than 2.4 million cataract surgeries between 1992 and 2021. During these 30 years, the cataract surgery rate rose from 3700 to 12 800. The coverage of NCR is very high including 93% of all cataract procedures in Sweden between 2010 and 2021. Independently of demographic changes, the proportion of operations of patients age 60 to 79 has increased while the proportion of 80 to 90+ has decreased. The median visual acuity of the first eye planned for surgery was 0.1 decimal in 1992 and has increased to 0.5 decimal in 2021. Patient-reported outcome measures have been registered with the Catquest-9SF questionnaire since 2008, demonstrating intervention at an earlier stage, but consistently favorable outcomes. Surgical complications have decreased; endophthalmitis has decreased from 0.10% to below 0.02%, and posterior capsule rupture from 2.8% to 0.6%.
本综述总结了瑞典国家白内障登记处(NCR)收集的数据,截至 2021 年底,该登记处包含了 1992 年至 2021 年间超过 240 万例白内障手术的数据。在这 30 年中,白内障手术率从 3700 例上升到 12800 例。NCR 的覆盖率非常高,包括 2010 年至 2021 年瑞典所有白内障手术的 93%。独立于人口变化,60 至 79 岁患者手术比例增加,而 80 至 90 岁以上患者手术比例减少。计划手术的第一只眼的中位数视力从 1992 年的 0.1 十进制提高到 2021 年的 0.5 十进制。自 2008 年以来,使用 Catquest-9SF 问卷登记了患者报告的结果测量指标,这表明干预更早,但结果一致良好。手术并发症减少;内眼炎从 0.10%下降到 0.02%以下,后囊破裂从 2.8%下降到 0.6%。